GE Healthcare Extends Collaboration and Development With Medipattern

GE Healthcare's (NYSE:GE - News) Vascular Ultrasound group and The Medipattern Corporation (TSX VENTURE:MKI - News) are pleased to announce their plan to collaborate in the creation of Ultrasound-based Vascular Imaging Quantification Tools (Vascular iQ(TM)). GE Healthcare and Medipattern confirmed their plans to collaborate by signing a definitive collaboration agreement. Medipattern will leverage technology developed in its Cadenza(TM) algorithm platform and extend it with additional functionality to create Vascular iQ. Medipattern will create a generalized version of the vascular product while building an exclusive version for GE Healthcare ultrasound systems, which will be available to the market through GE's well-established distribution to clinicians around the world.

"GE Healthcare's Vascular Ultrasound team is committed to developing new technology to image and analyze vascular disease, increasing diagnostic confidence, and speeding patient treatment," said Michael Arbaugh, GE Healthcare General Manager of GE Healthcare's Vascular Ultrasound division. "Our investment in dedicated vascular expertise, support of vascular education, and unique vascular technologies are evidence of this commitment. GE is actively developing new ultrasound products to capture distinctive diagnostic images."

source: Medipattern